Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/1999
06/08/1999US5910434 Separately inserting minimal gag-pol and minimal env open reading frames into expression plasmids, inserting plasmids into eukaryotic cells, propagating, screening for the gene expression; gene therapy
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme
06/08/1999CA2242308A1 Novel compounds
06/05/1999CA2218197A1 Therapeutic methods for prostate cancer
06/03/1999WO1999027136A1 Decreasing cell proliferation by decreasing levels of pp5
06/03/1999WO1999027134A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027123A2 Modified sv40 viral vectors
06/03/1999WO1999027122A1 Vectors inhibiting or delaying the binding of an immunodeficiency virus to cells
06/03/1999WO1999027121A1 Development of viruses resistant to inactivation by the human complement system
06/03/1999WO1999027110A1 Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity
06/03/1999WO1999027104A1 Histamine and serotonin binding molecules
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027102A1 Cd4+ t-lymphocyte protease genes and inhibitors thereof
06/03/1999WO1999027101A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027094A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
06/03/1999WO1999027093A2 The nip3 family of proteins
06/03/1999WO1999026980A1 Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
06/03/1999WO1999026969A1 Zoocin a immunity factor
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026664A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999WO1999026663A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999WO1999026662A1 A method for in vivo dna delivery using a needle free apparatus
06/03/1999WO1999026653A1 Dna vaccines against tick-borne flaviviruses
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026644A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999WO1999026480A1 Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
06/03/1999WO1999026475A1 ribG
06/03/1999WO1999026463A2 Tnf ligand family gene
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014353A3 Intrabody-mediated control of immune reactions
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999012576A3 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
06/03/1999WO1998037089A8 Matrix derived anti-hiv peptides and transdominant proteins
06/03/1999CA2641217A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2592380A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999CA2311642A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
06/03/1999CA2311237A1 Human proteins having transmembrane domains and dnas encoding these proteins
06/03/1999CA2311170A1 The nip3 family of proteins
06/03/1999CA2310987A1 Tnf ligand family gene
06/03/1999CA2310852A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999CA2310029A1 A method for in vivo dna delivery using a needle free apparatus
06/03/1999CA2309888A1 Decreasing cell proliferation by decreasing levels of pp5
06/03/1999CA2309809A1 Histamine and serotonin binding molecules
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/02/1999EP0919627A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919626A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919625A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919624A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918871A2 Afc1 and rce1:isoprenylated caax processing enzymes
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918861A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
06/02/1999EP0918787A1 Compositions and methods for antisense inhibition of protein translation
06/02/1999EP0918785A1 Cellular injury response element and uses thereof
06/02/1999EP0918540A1 Intradermal bovine polynucleotide vaccine
06/02/1999EP0918532A1 A novel method of detecting and treating cancer
06/02/1999EP0918511A2 Lipid-binding proteins and their therapeutic and diagnostic use
06/02/1999EP0918509A1 Biocompatible devices with foam scaffolds
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0680513B1 Lysosomal targeting of immunogens
06/02/1999CN1218513A Vectors based on recombinant defenctive viral genmoes, and their use in formulation of vaccines
06/02/1999CN1218512A Recombinant adenoviral vectors for human tumour gene therapy
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908845 Polyether nucleic acids
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999US5908780 Cells transformed or transfected with HCMV US2 gene
06/01/1999US5908635 Method for the liposomal delivery of nucleic acids
06/01/1999US5908623 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
06/01/1999US5908609 Screening methods for compounds useful in the regulation of body weight
05/1999
05/27/1999WO1999025877A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025863A1 Transfection and transfer of male germ cells for generation of transgenic species
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025851A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999WO1999025837A2 Method for producing virus-like particles on the basis of polyoma viruses
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025829A2 Cdk2 protein and cdk2 protein complexes
05/27/1999WO1999025819A2 Antisense oligonucleotides against tenascin for treating vitiligo
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025814A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy
05/27/1999WO1999025736A1 Chronic lymphocytic leukemia nucleotides and proteins
1 ... 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 ... 870